Insider Transactions in Q1 2021 at Smith A O Corp (AOS)
Insider Transaction List (Q1 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 29
2021
|
Gene C Wulf Director |
SELL
Open market or private sale
|
Direct |
15,000
-15.19%
|
$1,050,000
$70.0 P/Share
|
|
Mar 29
2021
|
Wallace E Goodwin SVP; President, Lochinvar, LLC |
SELL
Open market or private sale
|
Direct |
2,000
-10.61%
|
$140,000
$70.0 P/Share
|
|
Mar 29
2021
|
Wallace E Goodwin SVP; President, Lochinvar, LLC |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+9.59%
|
$34,000
$17.46 P/Share
|
|
Mar 29
2021
|
Daniel L Kempken SVP - Strategy & Corp. Dev. |
SELL
Open market or private sale
|
Direct |
2,000
-21.05%
|
$140,000
$70.0 P/Share
|
|
Mar 29
2021
|
Daniel L Kempken SVP - Strategy & Corp. Dev. |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+17.39%
|
$34,000
$17.46 P/Share
|
|
Mar 19
2021
|
Douglas Samuel Karge SVP - President NA Water Treat |
SELL
Payment of exercise price or tax liability
|
Direct |
284
-32.09%
|
$19,028
$67.49 P/Share
|
|
Mar 19
2021
|
Douglas Samuel Karge SVP - President NA Water Treat |
BUY
Grant, award, or other acquisition
|
Direct |
885
+50.0%
|
$59,295
$67.49 P/Share
|
|
Mar 18
2021
|
Daniel L Kempken SVP - Strategy & Corp. Dev. |
SELL
Open market or private sale
|
Direct |
2,400
-24.24%
|
$160,800
$67.5 P/Share
|
|
Mar 18
2021
|
Daniel L Kempken SVP - Strategy & Corp. Dev. |
BUY
Exercise of conversion of derivative security
|
Direct |
2,400
+19.51%
|
$26,400
$11.49 P/Share
|
|
Mar 12
2021
|
Gene C Wulf Director |
SELL
Open market or private sale
|
Direct |
1,000
-1.0%
|
$65,000
$65.24 P/Share
|
|
Mar 11
2021
|
Gene C Wulf Director |
SELL
Open market or private sale
|
Direct |
1,000
-0.99%
|
$65,000
$65.04 P/Share
|
|
Mar 10
2021
|
Daniel L Kempken SVP - Strategy & Corp. Dev. |
SELL
Open market or private sale
|
Direct |
2,000
-21.05%
|
$130,000
$65.0 P/Share
|
|
Mar 10
2021
|
Daniel L Kempken SVP - Strategy & Corp. Dev. |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+17.39%
|
$22,000
$11.49 P/Share
|
|
Mar 10
2021
|
Gene C Wulf Director |
SELL
Open market or private sale
|
Direct |
8,000
-3.69%
|
$512,000
$64.26 P/Share
|
|
Mar 09
2021
|
Gene C Wulf Director |
SELL
Open market or private sale
|
Direct |
500
-0.46%
|
$31,500
$63.38 P/Share
|
|
Mar 08
2021
|
Gene C Wulf Director |
SELL
Open market or private sale
|
Direct |
500
-0.46%
|
$31,000
$62.93 P/Share
|
|
Mar 05
2021
|
Daniel L Kempken SVP - Strategy & Corp. Dev. |
SELL
Open market or private sale
|
Direct |
2,000
-21.05%
|
$124,000
$62.5 P/Share
|
|
Mar 05
2021
|
Daniel L Kempken SVP - Strategy & Corp. Dev. |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+17.39%
|
$22,000
$11.93 P/Share
|
|
Mar 05
2021
|
Gene C Wulf Director |
SELL
Open market or private sale
|
Direct |
500
-0.45%
|
$31,000
$62.0 P/Share
|
|
Mar 04
2021
|
Ajita G Rajendra Director |
SELL
Bona fide gift
|
Direct |
9,911
-49.62%
|
-
|
|
Mar 04
2021
|
Ajita G Rajendra Director |
SELL
Bona fide gift
|
Indirect |
35,000
-12.57%
|
-
|
|
Mar 04
2021
|
Gene C Wulf Director |
SELL
Open market or private sale
|
Direct |
500
-0.45%
|
$31,000
$62.0 P/Share
|
|
Mar 03
2021
|
Ajita G Rajendra Director |
SELL
Bona fide gift
|
Indirect |
75,090
-21.24%
|
-
|
|
Mar 03
2021
|
Gene C Wulf Director |
SELL
Open market or private sale
|
Direct |
2,500
-2.21%
|
$155,000
$62.0 P/Share
|
|
Feb 24
2021
|
Gene C Wulf Director |
SELL
Open market or private sale
|
Direct |
500
-0.44%
|
$31,000
$62.0 P/Share
|
|
Feb 23
2021
|
Gene C Wulf Director |
SELL
Open market or private sale
|
Direct |
2,000
-1.73%
|
$124,000
$62.0 P/Share
|
|
Feb 12
2021
|
Mark D Smith Director |
SELL
Bona fide gift
|
Indirect |
632
-8.23%
|
-
|
|
Feb 12
2021
|
Mark D Smith Director |
BUY
Bona fide gift
|
Indirect |
316
+3.3%
|
-
|
|
Feb 12
2021
|
Patricia K Ackerman Senior Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
292
-7.68%
|
$17,520
$60.65 P/Share
|
|
Feb 12
2021
|
Patricia K Ackerman Senior Vice President |
BUY
Grant, award, or other acquisition
|
Direct |
930
+19.66%
|
$55,800
$60.65 P/Share
|
|
Feb 12
2021
|
Paul R Dana SVP, Global Operations |
SELL
Open market or private sale
|
Direct |
4,850
-49.64%
|
$291,000
$60.22 P/Share
|
|
Feb 12
2021
|
Paul R Dana SVP, Global Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
4,850
+33.17%
|
$150,350
$31.67 P/Share
|
|
Feb 12
2021
|
Paul R Dana SVP, Global Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
557
-10.17%
|
$33,420
$60.65 P/Share
|
|
Feb 12
2021
|
Paul R Dana SVP, Global Operations |
BUY
Grant, award, or other acquisition
|
Direct |
1,415
+20.53%
|
$84,900
$60.65 P/Share
|
|
Feb 12
2021
|
Wallace E Goodwin SVP; President, Lochinvar, LLC |
SELL
Payment of exercise price or tax liability
|
Direct |
473
-2.73%
|
$28,380
$60.65 P/Share
|
|
Feb 12
2021
|
Wallace E Goodwin SVP; President, Lochinvar, LLC |
BUY
Grant, award, or other acquisition
|
Direct |
1,200
+6.48%
|
$72,000
$60.65 P/Share
|
|
Feb 12
2021
|
Helen E Gurholt Vice President and Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
99
-6.2%
|
$5,940
$60.65 P/Share
|
|
Feb 12
2021
|
Helen E Gurholt Vice President and Controller |
BUY
Grant, award, or other acquisition
|
Direct |
265
+14.23%
|
$15,900
$60.65 P/Share
|
|
Feb 12
2021
|
Robert J Heideman Senior VP, CTO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,143
-10.25%
|
$68,580
$60.65 P/Share
|
|
Feb 12
2021
|
Robert J Heideman Senior VP, CTO |
BUY
Grant, award, or other acquisition
|
Direct |
2,430
+17.89%
|
$145,800
$60.65 P/Share
|
|
Feb 12
2021
|
Daniel L Kempken SVP - Strategy & Corp. Dev. |
SELL
Payment of exercise price or tax liability
|
Direct |
431
-5.43%
|
$25,860
$60.65 P/Share
|
|
Feb 12
2021
|
Daniel L Kempken SVP - Strategy & Corp. Dev. |
BUY
Grant, award, or other acquisition
|
Direct |
930
+10.49%
|
$55,800
$60.65 P/Share
|
|
Feb 12
2021
|
Charles T Lauber EVP & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
879
-3.15%
|
$52,740
$60.65 P/Share
|
|
Feb 12
2021
|
Charles T Lauber EVP & CFO |
BUY
Grant, award, or other acquisition
|
Direct |
1,870
+6.27%
|
$112,200
$60.65 P/Share
|
|
Feb 12
2021
|
Mark A Petrarca Senior Vice Pres. - H.R. & P.A |
SELL
Payment of exercise price or tax liability
|
Direct |
1,157
-1.27%
|
$69,420
$60.65 P/Share
|
|
Feb 12
2021
|
Mark A Petrarca Senior Vice Pres. - H.R. & P.A |
BUY
Grant, award, or other acquisition
|
Direct |
2,460
+2.63%
|
$147,600
$60.65 P/Share
|
|
Feb 12
2021
|
James F Stern Exec VP, General Counsel & Sec |
SELL
Payment of exercise price or tax liability
|
Direct |
1,758
-1.15%
|
$105,480
$60.65 P/Share
|
|
Feb 12
2021
|
James F Stern Exec VP, General Counsel & Sec |
BUY
Grant, award, or other acquisition
|
Direct |
3,740
+2.39%
|
$224,400
$60.65 P/Share
|
|
Feb 12
2021
|
David R Warren Senior VP & President and GM |
SELL
Payment of exercise price or tax liability
|
Direct |
758
-11.06%
|
$45,480
$60.65 P/Share
|
|
Feb 12
2021
|
David R Warren Senior VP & President and GM |
BUY
Grant, award, or other acquisition
|
Direct |
1,925
+21.93%
|
$115,500
$60.65 P/Share
|